People With Acute Calcium Pyrophosphate Face Doubled Risk for Fracture
By Lori Solomon HealthDay Reporter
MONDAY, April 29, 2024 -- Fracture risk is nearly doubled in individuals with acute calcium pyrophosphate (CPP) crystal arthritis, according to a study recently published in Arthritis & Rheumatology.
Sara K. Tedeschi, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared fracture risks (humerus, wrist, hip, or pelvis) in 1,148 patients with acute CPP crystal arthritis (1991 to 2023) versus 3,730 matched controls.
The researchers found that glucocorticoids and osteoporosis treatments were more frequent in the acute CPP crystal arthritis cohort, yet fracture incidence rates were twice as high in the acute CPP crystal arthritis cohort (11.7 per 1,000 person-years versus 5.5 per 1,000 person-years for controls). Results persisted even in an adjusted analysis (hazard ratio, 1.8).
"Although a number of studies have investigated clinical conditions preceding the diagnosis of CPPD [calcium pyrophosphate deposition], few have evaluated long-term outcomes in patients with CPPD," the authors write. "Our observation of elevated fracture risk in patients with acute CPP crystal arthritis supports the need for additional prospective studies of bone turnover markers, bone density, and effects of osteoporosis treatments in patients with CPPD, as well as future mediation analysis to understand the potential contribution of CPPD treatment on fracture risk."
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Severe Mental Illness Tied to Fragility Fractures in People 50 Years and Older
FRIDAY, Oct. 25, 2024 -- Severe mental illness (SMI) is associated with an increased likelihood of fragility fractures, while osteoporosis may be underdiagnosed, according to a...
Mortality Increased With Delayed Admission for Patients With Hip Fracture
THURSDAY, Oct. 10, 2024 -- For patients with hip fracture, delayed admission is associated with increased mortality risk, according to a study published online Oct. 8 in Emergency...
Liposomal Bupivacaine No Aid for Intracapsular Femoral Neck Fracture Outcomes
TUESDAY, Oct. 8, 2024 -- Liposomal bupivacaine is not associated with significant improvement in postoperative pain or function or hospital length of stay following hip...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.